At a glance
ClinicalIndex Comparison RecordN/ACompleted· 178 enrolled
Drug / intervention
Interbody Fusiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lumbar Degenerative Disc Disease Treated With
In Brief
A clinical study evaluating Interbody Fusion for Lumbar Degenerative Disc Disease. Completed, enrolled 178 participants.
Detailed Summary
Multi-center, prospective nonrandomized study of treatment for 1 and 2 level degenerative disc disease between L2 and S1. Patients will be followed for a minimum of 2 years. The primary objective of this study to measure fusion success in patients with lumbar degenerative disc disease using the ATB and ALIF/FRA Spacer. The Secondary objective is evaluation of the patient's quality of life, pain and function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLumbar Degenerative Disc Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2004
Primary CompletionMay 2009
Study CompletionFeb 2011
First PostedMar 2011
TodayJul 2026
First PostedMar 25, 2011
Enrollment StartApr 1, 2004
Primary CompletionMay 1, 2009
Study CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 15.3 years ago
Interventions
Interbody Fusiondevice
allograft spacer + anterior plate